BeaconEquity Initiates Independent Research Coverage for Keryx ... - Trading Markets (press release) PDF Print
Trading Markets (press release)Zerenex is in phase II clinical development for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end stage renal disease

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.